Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma

Table 2

Univariate Cox regression analysis of 17 genes and overall survival of BLCA in two databases.

Gene name	GEO		TCGA
	HR (95% CI for HR)	value	HR (95% CI for HR)	value
ATP4A	13 (1.1-140)	3.92-02	1.2 (1-1.4)	4.51-02
CCDC73	29 (2.4-360)	8.45-03	2.1 (1.3-3.5)	3.69-03
CNTNAP4	35 (1.5-850)	2.75-02	1.1 (1-1.3)	4.09-02
CRB1	0.014 (0.00019-0.98)	4.88-02	0.83 (0.68-1)	4.85-02
EWSR1	5.4 (1.7-18)	5.05-03	10 (1.9-54)	6.87-03
FCGR3B	0.2 (0.043-0.9)	3.59-02	0.77 (0.62-0.95)	1.37-02
FRYL	0.053 (0.005-0.56)	1.48-02	0.24 (0.083-0.7)	9.17-03
GDF7	42 (1.6-1100)	2.44-02	1.4 (1.1-1.9)	2.3-02
GSG1L	520 (19-14000)	2.14-04	1.2 (1-1.4)	3.33-02
PRDM14	20 (1.4-270)	2.58-02	1.2 (1-1.4)	2.3-02
PRKDC	0.59 (0.4-0.86)	6.62-03	0.41 (0.21-0.8)	9.25-03
RER1	3.3 (1.2-8.9)	1.91-02	6 (1.5-24)	1.12-02
SYNPO	0.02 (0.00046-0.86)	4.15-02	0.46 (0.26-0.81)	7.35-03
XKR8	21 (1.4-300)	2.71-02	3.7 (1.2-12)	2.55-02
ZNF284	54 (1.4-2200)	3.37-02	2.5 (1-6.1)	4.38-02
ZNF680	2.3 (1.1-4.7)	2.48-02	2.1 (1-4)	3.65-02
ZNF780B	27 (1.8-390)	1.63-02	2.7 (1.3-5.6)	9.42-03